The Maryland Research and Development Tax Credit: A Comprehensive Analysis of Controlled Group Aggregation and Proportionate Share Allocation

In the context of the Maryland Research and Development (R&D) tax credit, “proportionate share” refers to the mandatory method of dividing a single, consolidated group credit among individual members of a controlled group based on their respective contributions to the group’s total qualified research expenses. This regulatory mechanism ensures that while a corporate family is treated as one taxpayer for the purpose of statutory limits and application, the resulting tax benefit is distributed to each subsidiary in direct proportion to its specific innovation activity within the state.

The Maryland Research and Development tax credit represents one of the state’s most significant fiscal tools for incentivizing technological innovation and economic growth. Administered through a collaborative effort between the Maryland Department of Commerce and the Comptroller of Maryland, the program has undergone substantial legislative evolution, most recently through the passage of Senate Bill 196 in 2021.1 To understand the concept of proportionate share, one must first appreciate the “single taxpayer” doctrine that governs affiliated corporations and entities under common control. This doctrine, rooted in Maryland Tax-General Article § 10-721, mirrors federal standards to ensure that corporate structures cannot be artificially manipulated to circumvent the statewide funding caps or the individual applicant maximums.3 The allocation of the credit via a proportionate share formula is not merely an accounting preference but a statutory requirement that dictates how a group’s certified credit “pushes down” to the tax returns of its individual components.

Statutory Foundations and the Single Taxpayer Doctrine

The legal architecture of the Maryland R&D tax credit is built upon the principle of aggregation. Under Maryland Tax-General § 10-721(e)(1)(i), the law explicitly mandates that all members of the same controlled group of corporations, as defined under § 41(f) of the Internal Revenue Code (IRC), must be treated as a single taxpayer for the purposes of the credit.4 This integration with federal tax law provides a standardized framework for identifying which entities must be grouped together during the application process. The primary objective of this aggregation is to prevent the fragmentation of research expenses across multiple legal entities to bypass the individual $250,000 per-applicant cap or to leverage multiple “base amount” calculations that might otherwise yield a higher aggregate credit than a single consolidated calculation.2

Once the group is established as a single taxpayer, § 10-721(e)(1)(ii) introduces the “proportionate share” requirement. This clause stipulates that the credit allowable to each member shall be its proportionate share of the qualified research expenses (QREs) giving rise to the credit.4 This creates a two-tiered process: first, the Department of Commerce calculates a single credit amount for the entire group, often subject to a statewide proration due to oversubscription of the $12 million annual fund; second, that final certified amount is distributed back to the individual members.6 This ensure that the entity actually incurring the research costs—and thus bearing the economic risk of innovation—receives the corresponding tax benefit on its specific Maryland income tax return.

Alignment with Internal Revenue Code Section 41(f)

Maryland’s reliance on IRC § 41(f) for the definition of a controlled group ensures that the state’s tax environment remains consistent with federal reporting standards, which is vital for multi-state corporations. Under the federal guidelines adopted by Maryland, a controlled group includes:

• Parent-Subsidiary Groups: Chains of corporations connected through stock ownership where a common parent owns at least 80% of at least one other corporation, and 80% of each corporation is owned by one or more members of the group.8
• Brother-Sister Groups: Two or more corporations where five or fewer individuals, estates, or trusts own at least 80% of the voting power or value, and have more than 50% identical ownership across the entities.8
• Combined Groups: Groups where three or more organizations are members of either a parent-subsidiary or brother-sister group, and at least one is a common parent and a member of a brother-sister group.8

By utilizing these definitions, Maryland captures a wide array of business structures, including not just C corporations but also trades or businesses under common control, whether or not they are incorporated.3 This ensures that the proportionate share allocation remains applicable to partnerships, S corporations, and limited liability companies (LLCs) that are part of a larger controlled framework.

The Mathematical Mechanism of Proportionate Share Allocation

The calculation of a member’s proportionate share is a deterministic process that uses the individual entity’s qualified research expenses as the numerator and the group’s total Maryland qualified research expenses as the denominator. This ratio is then applied to the total credit amount certified by the Department of Commerce for the entire controlled group.6

The Allocation Formula

The specific regulatory guidance provided in COMAR 03.04.10.09 outlines the following formula for determining the allowable credit for each group member 9:

$$Credit_{Member} = Total\ Group\ Certified\ Credit \times \left( \frac{QRE_{Member}}{Total\ Group\ QRE} \right)$$

This formula remains constant regardless of whether the group’s total credit was limited by the $250,000 individual applicant cap or reduced by the statewide proration fraction.2 It is important to note that the “Total Group QRE” in the denominator refers only to the expenses incurred by members of the controlled group that were included in the consolidated application to the Department of Commerce.

Integration with Statewide Proration

One of the most complex aspects of the Maryland R&D credit is that the “Total Group Certified Credit” in the formula above is rarely 10% of the group’s excess expenses. Because the program is limited to a $12 million annual cap ($8.5 million for non-small businesses and $3.5 million for small businesses), the Department of Commerce must prorate all applications when the total requested credits exceed these amounts.7

In recent years, the program has been significantly oversubscribed. For the 2024 evaluation cycle, the Department received over $38 million in applications for only $12 million in available funds, resulting in a proration rate of approximately 31.32%.10 This means that the “Total Group Certified Credit” is calculated as:

$$Total\ Group\ Certified\ Credit = (Excess\ QREs \times 10\%) \times Proration\ Fraction$$

Consequently, the proportionate share allocation must be performed after the state has applied its own proration to the group’s requested amount. This ensures that the reduction in credit value caused by oversubscription is shared equitably among all members of the corporate family in proportion to their research activities.

Local State Revenue Office Guidance: Commerce vs. Comptroller

The administration of the Maryland R&D tax credit is a bifurcated process. The Maryland Department of Commerce is responsible for the “front-end” certification—receiving applications, verifying eligibility, and determining the credit amount.6 The Comptroller of Maryland handles the “back-end” tax administration—processing the credit on tax returns, managing addition modifications, and conducting audits.3

Department of Commerce: Centralized Application Guidelines

The Department of Commerce provides explicit guidance for affiliated corporations with multiple subsidiaries in Maryland. To streamline the certification process, the Department requires a centralized application approach. According to official FAQs, if a corporation has several subsidiaries in Maryland conducting research and development, only the parent company (or a designated common parent) should apply for the credit on behalf of the entire group.6

The application must aggregate the QREs and the gross receipts for all members of the group over the current year and the preceding four years to establish the “Maryland Base Amount”.7 This consolidated base amount is critical because research growth is measured at the group level. A subsidiary might show a massive increase in research spending, but if another subsidiary in the same controlled group saw a corresponding decrease, the group’s total credit would reflect only the net growth across the entire “single taxpayer” entity.

Comptroller of Maryland: Reporting and the “Add-Back” Requirement

Once the Department of Commerce issues a certification letter to the parent company, the Comptroller’s guidance dictates how the individual members claim their share. Because the Maryland R&D credit is calculated based on expenses that are already deductible for federal income tax purposes, Maryland law requires a “taxpayer neutrality” adjustment known as the addition modification.17

Under Maryland Tax-General § 10-205(i) and § 10-306, any taxpayer claiming the R&D credit must add the amount of the credit back to their federal adjusted gross income (for individuals) or federal taxable income (for corporations) when filing their Maryland return.17 For a controlled group using proportionate share, this means:

1. Individual Filing: Each member files its own Maryland return (or is included in a consolidated Maryland return if eligible) and claims its specific proportionate share of the credit.3
2. Individual Add-Back: Each member must also perform an addition modification equal to the specific amount of credit it is claiming.18 This ensures that the entity does not receive both a deduction and a credit for the same dollar of research spending at the state level.

Pass-Through Entity (PTE) Specifics

For controlled groups that include partnerships, S corporations, or LLCs, the Comptroller provides further instructions through COMAR 03.04.10.13. The credit amount computed for the PTE is allocated among its owners as agreed to in writing by the owners.20 In the absence of a written agreement, the credit is allocated in the same proportion as other items of income or loss.20

The PTE must provide each member with a statement (typically a Maryland Schedule K-1) showing the member’s share of the credit.20 This statement is then attached to the individual member’s tax return. If the PTE is part of a larger controlled group, the “proportionate share” calculation must occur first at the group level to determine the PTE’s total credit, which is then further subdivided among the PTE’s owners.

Detailed Analysis of Small Business and Asset Aggregation

A pivotal component of the Maryland R&D credit is the preferential treatment of small businesses, particularly regarding the refundability of the credit. However, the definition of a “small business” for this program is strictly tied to asset limits, which are also subject to controlled group aggregation rules.

The $5 Million Net Book Value Asset Test

Under SB 196 (2021), a small business is defined as a for-profit entity with “net book value assets” totaling less than $5 million at the beginning or the end of the taxable year for which the expenses are incurred.6 “Net book value assets” are defined as the total value of assets—including intangibles like patents and trademarks—minus depreciation and amortization, but notably not including liabilities.2

Aggregation of Assets within a Controlled Group

For companies that are members of a controlled group, the $5 million asset test is generally applied to the group as a whole. This prevents a large corporation from spinning off R&D functions into a small subsidiary to qualify for the $3.5 million small business set-aside or to gain the benefit of refundability.21 If the aggregate net book value assets of all members of the controlled group exceed $5 million, then no individual member of that group—regardless of how small its own balance sheet may be—can qualify as a small business for the purposes of the Maryland R&D credit.4

This has profound implications for startups and early-stage technology companies that may be partially owned by larger venture capital firms or corporate parents. If the ownership structure triggers a “controlled group” designation under IRC § 41(f), the startup may find itself ineligible for the small business refund, even if it has no revenue and minimal independent assets.22

Practical Example: Multi-Entity Controlled Group Allocation

To illustrate the interplay of these rules, consider a hypothetical corporate group, “BioNexus Global,” which consists of a parent company and three subsidiaries operating in Maryland.

Step 1: Group Financial and R&D Profile

BioNexus Global is determined to be a controlled group under IRC § 41(f) because the parent company owns 100% of each subsidiary. For the 2024 tax year, the group’s Maryland activities were as follows:

Step 2: Determining Small Business Status

Although Subsidiary C has only $500,000 in assets, the “single taxpayer” rule requires evaluating the entire group. Because the group’s aggregate assets ($14,000,000) exceed the $5 million threshold, the entire group is classified as “Not a Small Business”.4 They must apply for credits from the $8.5 million general pool, and their credits will be non-refundable.7

Step 3: Calculating the Group Credit

The group first determines its Maryland Base Amount. For simplicity, assume the group’s average QRE-to-Gross-Receipts ratio over the prior four years resulted in a Base Amount of $3,000,000.

1. Group Excess QREs: $5,000,000 – $3,000,000 = $2,000,000.
2. Tentative Group Credit: 10% of $2,000,000 = $200,000.

Step 4: Applying Proration and Caps

Suppose the Department of Commerce is oversubscribed in the non-small business pool and applies a 35% proration rate for that year.

• Total Certified Group Credit: $200,000 \times 0.35 = \$70,000$.

Step 5: Proportionate Share Allocation to Subsidiaries

The parent company receives a certification letter for $70,000. It must now allocate this to Subsidiaries A, B, and C based on their share of the $5,000,000 in group QREs.

• Subsidiary A Share: $(\$2,500,000 / \$5,000,000) \times \$70,000 = \$35,000$.
• Subsidiary B Share: $(\$1,500,000 / \$5,000,000) \times \$70,000 = \$21,000$.
• Subsidiary C Share: $(\$1,000,000 / \$5,000,000) \times \$70,000 = \$14,000$.

Step 6: Filing and Compliance

Each subsidiary will file an amended Maryland return. Subsidiary A will claim a $35,000 credit and simultaneously report a $35,000 addition modification to its income.5 Because the credit is non-refundable for this group, if Subsidiary C only has a $5,000 tax liability, it will use $5,000 of its credit and carry forward the remaining $9,000 for up to seven years.6

Oversubscription Trends and the Economic Reality of Proration

The “proportionate share” of a Maryland R&D credit is often significantly lower than the 10% statutory rate suggests. A deep dive into the 2024 Evaluation Report by the Department of Legislative Services (DLS) reveals that the program’s popularity has created a permanent state of oversubscription.10

The $12 Million Ceiling

Since 2015, the annual aggregate funding has been capped at $12 million.5 Despite legislative attempts to manage this—such as the repeal of the “basic” credit which used to offer 3% on all expenses—the demand for the “growth” credit (10% on excess expenses) continues to far exceed available funds.2

The DLS report notes that this has an “unintentional consequence” of creating unequal effective credit rates. While all businesses are subject to the same proration fraction in a given year, the actual value of the credit as a percentage of R&D spending varies based on how high a company’s base amount is.10 For companies in a controlled group, this makes the proportionate share calculation even more critical, as the “diluted” value of the credit must be accurately distributed to justify the administrative cost of the application.

Administrative Burden of Proration

Chapter 6 of the 2024 Evaluation Report highlights that the constant necessity for proration adds significant administrative layers for both the state and the businesses.10 Companies must perform their financial planning based on a 10% credit, only to receive a certification months later that might be for less than 4% of their excess expenses.10 For controlled groups, this requires a secondary round of internal accounting to adjust the “proportionate share” entries on each subsidiary’s books once the final proration fraction is known.

Data synthesized from DLS 2024 Evaluation Report.10

Specialized Context: Montgomery County Supplement

An interesting ripple effect of the “proportionate share” concept occurs at the local level in Montgomery County. Montgomery County offers a local supplement to the Maryland Biotechnology Investment Incentive Tax Credit, which follows a similar logic to the state’s R&D allocation rules.23

Under Montgomery County Code § 20-76A, the county provides an additional supplement to investors in local biotech companies.23 Bill 34-11 revised the formula for this supplement to ensure it stayed within local budget appropriations. Much like the state R&D credit, if the total requested supplements exceed the county’s appropriation, each applicant receives a “proportionate share” of the total funds.23

The formula used by the county is:

$$Supplement = Total\ County\ Appropriation \times \left( \frac{Applicant’s\ State\ Credit}{Total\ State\ Credits\ of\ all\ County\ Applicants} \right)$$

This demonstrates that the “proportionate share” methodology is a pervasive theme in Maryland tax law, used whenever a fixed pool of incentive dollars must be distributed across an oversubscribed group of eligible participants.23

Strategic Considerations for Mergers, Acquisitions, and Dispositions

In the corporate world, entities within a controlled group are frequently bought, sold, or reorganized. Maryland’s R&D tax credit regulations include specific provisions for how these transactions affect the calculation of the Maryland Base Amount and the subsequent allocation of credits.

The Continuity of Research History

When a company in a controlled group is involved in an acquisition or merger, the “single taxpayer” entity must adjust its historical research data. Under COMAR 03.04.10.10, if Company A acquires Company B, the base amount for the new consolidated group must include the historical QREs and Maryland gross receipts of both entities for the four preceding years.6 This prevents a company from “resetting” its base amount to zero through a merger to artificially inflate its “growth” credit.7

Asset vs. Stock Purchases

The treatment of “proportionate share” also depends on the structure of the transaction:

• Stock Purchase: If a corporation buys the stock of another entity, the acquired entity remains a legal person. Its share of any previously certified but unused R&D credits (the carryforward) generally stays with the entity and can be used by the new parent company on a consolidated or separate return.6
• Asset Purchase: If only the assets of a company are purchased, the R&D credits do not carry over to the buyer. The legal entity that was originally certified for the credit remains the owner of that credit, even if it no longer has active operations.6

This distinction is a critical point of negotiation in M&A activity for Maryland-based tech firms. A “proportionate share” of a million-dollar R&D carryforward can be a significant asset, but only if the transaction is structured to preserve the legal entity that holds the certification.

Compliance, Documentation, and Audit Preparedness

Given the complexity of the proportionate share rules and the high rate of proration, the Comptroller’s Office maintains rigorous audit standards to ensure that credits are not over-claimed.

The Four-Part Test and Substantiation

To qualify for the credit, the research must meet the federal “Four-Part Test” defined in IRC § 41(d): it must be technological in nature, intended to eliminate uncertainty, involve a process of experimentation, and be for a permitted purpose.11 For members of a controlled group, the burden of proof is individual. Even if the group is treated as a “single taxpayer” for the application, during an audit, each subsidiary must provide contemporaneous documentation for its specific portion of the QREs.7

Documentation should include:

• Payroll Records: Identifying employees and the percentage of their time spent on qualified activities.7
• Project Lists: Detailed descriptions of the “business components” being developed.24
• General Ledger Accounts: Tracking supplies and contract research costs specifically linked to Maryland-based projects.7

Recent IRS and State Trends

Recent IRS updates to Form 6765, which Maryland follows, now require more qualitative information, such as the identification of “technical unknowns” and the specific allocation of officer wages.24 Maryland revenue office guidance suggests that taxpayers who fail to maintain these detailed records at the subsidiary level risk having their “proportionate share” of the group credit disallowed during a state audit, even if the group’s total expenses were verified.7

Conclusion: The Integrated Future of Maryland Innovation Incentives

The concept of Proportionate Share within the Maryland R&D tax credit framework is a vital component of a system designed to balance aggressive economic incentivization with strict fiscal responsibility. By mandating the aggregation of controlled groups into a single taxpayer, Maryland ensures that its $12 million innovation fund is not depleted by corporate maneuvering. Simultaneously, by requiring the proportionate allocation of those credits back to individual subsidiaries, the state maintains a transparent and equitable tax system where the benefits of innovation follow the entities that perform the work.

For business leaders and tax professionals, the “proportionate share” rule necessitates a high degree of inter-company coordination. It requires a holistic view of a corporate group’s Maryland footprint—considering not just current research spending but also the aggregate asset values that determine small business refundability and the historical gross receipts that form the base amount. As the program continues to be oversubscribed, the strategic value of every dollar of credit increases, making the accuracy of these allocations and the robustness of the supporting documentation more critical than ever. Whether a company is a burgeoning biotech startup in Montgomery County or a multi-national manufacturer with multiple Maryland subsidiaries, mastering the nuances of credit allocation is essential for maximizing the state’s support for their research and development efforts.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/